Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Bullboard Posts
Post by Str8Shuteron Apr 09, 2020 3:46pm
198 Views
Post# 30895560

Potential for Serology Testing via SZLS Telehealth Platform

Potential for Serology Testing via SZLS Telehealth PlatformNormally, I would say it's unlikely to see any SZLS developments announced over the weekend, but this Easter long weekend might be an exception, IMHO.  One can see in the media that there has been increasing discussion and awareness of the urgent need to expedite and scale up antibody testing across the continent, if there's any hope of incrementally allowing non-essential workers back to work (i.e. to help restart the stalled economy). 

Every day counts, and a confirmatory announcement that SZLS's Telehealth Platform will be utilized for serology tests could come sooner than most folks assume.  At the current levels, I believe that the effect on the SP could also be a lot more significant than most appreciate.

FOMO got the best of me when I thought a little more about this angle, and so I feel a lot better after buying a few more shares today.  GLTA!
Bullboard Posts